Related Experiment Video
Updated: Mar 22, 2026

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases
Published on: September 6, 2024
Interaction with the Paxillin LD1 Motif Relieves MEKK2 Auto-inhibition
Michael P Kahle1, Bruce D Cuevas1
1Department of Molecular Pharmacology and Therapeutics, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA.
Abstract:
The cell signaling molecule MEK kinase 2 (MEKK2) is a key upstream regulator of MAPK activity that regulates numerous cellular functions, but the mechanisms that control MEKK2 activity are not well understood. Recently, we reported that MEKK2 both binds and promotes ubiquitylation of the scaffold protein paxillin, and thereby modulates the composition of adhesion complexes. In this study, we have extended our examination of this interaction and report that recombinant paxillin is sufficient to induce MEKK2 auto-phosphorylation. Furthermore, we utilize siRNA-mediated paxillin expression knockdown to reveal that MEKK2 activity is reduced in paxillin-deficient cells. Finally, we show that the paxillin leucine-rich motif 1 (LD1) is sufficient to bind to the MEKK2 amino terminal region and activate MEKK2. Taken together, our results show for the first time that paxillin association promotes MEKK2 activation and reveal the existence of a novel bi-directional regulatory relationship between MEKK2 and paxillin.
Insights
Paxillin binding and ubiquitylation activate MEK kinase 2 (MEKK2), a key regulator of MAPK signaling. This study reveals a novel bi-directional regulatory relationship between MEKK2 and paxillin.
Area of Science:
- Cellular Biology
- Molecular Signaling
Background:
- MEK kinase 2 (MEKK2) is a crucial regulator of MAPK activity, influencing diverse cellular functions.
- Mechanisms controlling MEKK2 activity remain incompletely understood.
- Previous work demonstrated MEKK2 binds and promotes ubiquitylation of paxillin, altering adhesion complexes.
Purpose of the Study:
- To further investigate the interaction between MEKK2 and paxillin.
- To elucidate the role of paxillin in MEKK2 activation.
- To identify specific paxillin domains involved in MEKK2 regulation.
Main Methods:
- Recombinant protein expression and purification.
- In vitro kinase assays to measure MEKK2 auto-phosphorylation.
- siRNA-mediated gene knockdown to assess MEKK2 activity in paxillin-deficient cells.
- Analysis of protein-protein interactions using specific paxillin domains.
Main Results:
- Recombinant paxillin induced MEKK2 auto-phosphorylation.
- MEKK2 activity was significantly reduced in cells with depleted paxillin.
- The paxillin Leucine-Rich Motif 1 (LD1) was sufficient for binding to MEKK2's N-terminal region and activating MEKK2.
- Demonstrated paxillin association promotes MEKK2 activation.
Conclusions:
- Paxillin directly promotes MEKK2 activation through its LD1 domain.
- Established a novel bi-directional regulatory relationship between MEKK2 and paxillin.
- Provides new insights into the regulation of MAPK signaling pathways.
Related Concept Videos
The JAK-STAT Signaling Pathway
Abnormal Proliferation
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
The Intrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

